38 related articles for article (PubMed ID: 12499249)
1. Inhibitory role of TRIP-Br1 oncoprotein in anticancer drug-mediated programmed cell death via mitophagy activation.
Jung S; Myagmarjav D; Jo T; Lee S; Han S; Quynh NTN; Anh NH; Vu SH; Choi Y; Lee MS
Int J Biol Sci; 2022; 18(9):3859-3873. PubMed ID: 35813469
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory Role of TRIP-Br1/XIAP in Necroptosis under Nutrient/Serum Starvation.
Sandag Z; Jung S; Quynh NTN; Myagmarjav D; Anh NH; Le DT; Lee BS; Mongre RK; Jo T; Lee M
Mol Cells; 2020 Mar; 43(3):236-250. PubMed ID: 32050753
[TBL] [Abstract][Full Text] [Related]
3. Sulforaphane Decrease of SERTAD1 Expression Triggers G1/S Arrest in Breast Cancer Cells.
Cheng AC; Shen CJ; Hung CM; Hsu YC
J Med Food; 2019 May; 22(5):444-450. PubMed ID: 31084542
[TBL] [Abstract][Full Text] [Related]
4. Sei-1 promotes double minute chromosomes formation through activation of the PI3K/Akt/BRCA1-Abraxas pathway and induces double-strand breaks in NIH-3T3 fibroblasts.
Tian X; Liu C; Wang X; Wang F; Wang L; Xu L; Ma J; Gao Y; Bao Y; Wang F; Sun L; Wei J; Lin C; Zhang H; Zhu G; Guan X; Fu S; Zhang C
Cell Death Dis; 2018 Mar; 9(3):341. PubMed ID: 29497033
[TBL] [Abstract][Full Text] [Related]
5. Met promotes the formation of double minute chromosomes induced by Sei-1 in NIH-3T3 murine fibroblasts.
Bao Y; Liu J; You J; Wu D; Yu Y; Liu C; Wang L; Wang F; Xu L; Wang L; Wang N; Tian X; Wang F; Liang H; Gao Y; Cui X; Ji G; Bai J; Yu J; Meng X; Jin Y; Sun W; Guan XY; Zhang C; Fu S
Oncotarget; 2016 Aug; 7(35):56664-56675. PubMed ID: 27494853
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Suprabasin is Associated with Proliferation and Tumorigenicity of Esophageal Squamous Cell Carcinoma.
Zhu J; Wu G; Li Q; Gong H; Song J; Cao L; Wu S; Song L; Jiang L
Sci Rep; 2016 Feb; 6():21549. PubMed ID: 26899563
[TBL] [Abstract][Full Text] [Related]
7. The biological role of actinin-4 (ACTN4) in malignant phenotypes of cancer.
Honda K
Cell Biosci; 2015; 5():41. PubMed ID: 26288717
[TBL] [Abstract][Full Text] [Related]
8. FH535 inhibited metastasis and growth of pancreatic cancer cells.
Wu MY; Liang RR; Chen K; Shen M; Tian YL; Li DM; Duan WM; Gui Q; Gong FR; Lian L; Li W; Tao M
Onco Targets Ther; 2015; 8():1651-70. PubMed ID: 26185454
[TBL] [Abstract][Full Text] [Related]
9. Tumor heterogeneity in the recurrence of epithelial ovarian cancer demonstrated by polycomb group proteins.
Gui T; Bai H; Zeng J; Zhong Z; Cao D; Cui Q; Chen J; Yang J; Shen K
Onco Targets Ther; 2014; 7():1705-16. PubMed ID: 25285018
[TBL] [Abstract][Full Text] [Related]
10. Coordinated expression of cyclin-dependent kinase-4 and its regulators in human oral tumors.
Poi MJ; Knobloch TJ; Sears MT; Uhrig LK; Warner BM; Weghorst CM; Li J
Anticancer Res; 2014 Jul; 34(7):3285-92. PubMed ID: 24982332
[TBL] [Abstract][Full Text] [Related]
11. p34 is a novel regulator of the oncogenic behavior of NEDD4-1 and PTEN.
Hong SW; Moon JH; Kim JS; Shin JS; Jung KA; Lee WK; Jeong SY; Hwang JJ; Lee SJ; Suh YA; Kim I; Nam KY; Han S; Kim JE; Kim KP; Hong YS; Lee JL; Lee WJ; Choi EK; Lee JS; Jin DH; Kim TW
Cell Death Differ; 2014 Jan; 21(1):146-60. PubMed ID: 24141722
[TBL] [Abstract][Full Text] [Related]
12. Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer.
Li J; Poi MJ; Tsai MD
Biochemistry; 2011 Jun; 50(25):5566-82. PubMed ID: 21619050
[TBL] [Abstract][Full Text] [Related]
13. 19q13 amplification is associated with high grade and stage in pancreatic cancer.
Kuuselo R; Simon R; Karhu R; Tennstedt P; Marx AH; Izbicki JR; Yekebas E; Sauter G; Kallioniemi A
Genes Chromosomes Cancer; 2010 Jun; 49(6):569-75. PubMed ID: 20232484
[TBL] [Abstract][Full Text] [Related]
14. Normal proliferation and tumorigenesis but impaired pancreatic function in mice lacking the cell cycle regulator sei1.
Fernandez-Marcos PJ; Pantoja C; Gonzalez-Rodriguez A; Martin N; Flores JM; Valverde AM; Hara E; Serrano M
PLoS One; 2010 Jan; 5(1):e8744. PubMed ID: 20090907
[TBL] [Abstract][Full Text] [Related]
15. TRIP-Br2 promotes oncogenesis in nude mice and is frequently overexpressed in multiple human tumors.
Cheong JK; Gunaratnam L; Zang ZJ; Yang CM; Sun X; Nasr SL; Sim KG; Peh BK; Rashid SB; Bonventre JV; Salto-Tellez M; Hsu SI
J Transl Med; 2009 Jan; 7():8. PubMed ID: 19152710
[TBL] [Abstract][Full Text] [Related]
16. Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients.
Schaner ME; Davidson B; Skrede M; Reich R; Flørenes VA; Risberg B; Berner A; Goldberg I; Givant-Horwitz V; Tropè CG; Kristensen GB; Nesland JM; Børresen-Dale AL
Mol Cancer; 2005 Jul; 4():26. PubMed ID: 16042759
[TBL] [Abstract][Full Text] [Related]
17. Identification of a candidate oncogene SEI-1 within a minimal amplified region at 19q13.1 in ovarian cancer cell lines.
Tang TC; Sham JS; Xie D; Fang Y; Huo KK; Wu QL; Guan XY
Cancer Res; 2002 Dec; 62(24):7157-61. PubMed ID: 12499249
[TBL] [Abstract][Full Text] [Related]
18. Isolation of DNA sequences amplified at chromosome 19q13.1-q13.2 including the AKT2 locus in human pancreatic cancer.
Miwa W; Yasuda J; Murakami Y; Yashima K; Sugano K; Sekine T; Kono A; Egawa S; Yamaguchi K; Hayashizaki Y; Sekiya T
Biochem Biophys Res Commun; 1996 Aug; 225(3):968-74. PubMed ID: 8780719
[TBL] [Abstract][Full Text] [Related]
19. Amplification of 19q13.1-q13.2 sequences in ovarian cancer. G-band, FISH, and molecular studies.
Thompson FH; Nelson MA; Trent JM; Guan XY; Liu Y; Yang JM; Emerson J; Adair L; Wymer J; Balfour C; Massey K; Weinstein R; Alberts DS; Taetle R
Cancer Genet Cytogenet; 1996 Mar; 87(1):55-62. PubMed ID: 8646743
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
